Diphtheria toxoid and acellular pertussis (Tdap) and quadrivalent meningococcal conjugate (MenACWY) vaccination coverage for adolescents remained around 90% in 2025, and human papillomavirus (HPV) vaccination did not increase for the fourth consecutive year, according to research published in the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Stagnation in HPV Vaccination Rates Among U.S. Adolescents Raises Public Health Concerns
Vaccination coverage for adolescents in the U.S. remained stable at around 90% for Tdap and MenACWY vaccines, while HPV vaccination rates stagnated for the fourth year. This data, published by the CDC, highlights ongoing public health challenges. Understanding vaccination trends is crucial for Iran as it navigates its own health policies and international relations.
👥 Key Players
📰 What Happened
Vaccination rates for Tdap and MenACWY vaccines in U.S. adolescents remained stable at around 90%, while HPV vaccination rates did not increase for the fourth consecutive year, according to a CDC report.
- Tdap and MenACWY vaccination coverage remained around 90%.
- HPV vaccination rates have stagnated for four years.
💡 Why It Matters
📚 Background
Vaccination is a critical public health tool to prevent diseases, and understanding trends in vaccination rates is essential for effective health policy.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%